VKTX240419C00044000 Option on Viking Therapeutics
| VKTX Stock | USD 62.75 1.18 1.92% |
Viking Therapeutics' option chain provides insight into all available option contracts written on Viking Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Viking Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Viking option contract.
In The Money vs. Out of Money Option Contracts on Viking Therapeutics
Analyzing Viking Therapeutics' in-the-money options over time can help investors to take a profitable long position in Viking Therapeutics regardless of its overall volatility. This is especially true when Viking Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Viking Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Viking Therapeutics' stock while costing only a fraction of its price.
Viking Therapeutics' latest option contracts expiring on 2024-05-31 are carrying combined implied volatility of 102.96 with a put-to-call open interest ratio of 0.42 over 120 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-05-31. The current put volume is at 2116, with calls trading at the volume of 3040. This yields a 0.7 put-to-call volume ratio. The Viking Therapeutics option chain provides detailed quote and price information for the current Viking Therapeutics option contracts. It shows all of Viking Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-31 Option Contracts
Viking Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Viking Therapeutics' lending market. For example, when Viking Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Viking Therapeutics, he or she must hedge the risk by shorting Viking Therapeutics stock over its option's life.
2024-05-31
The chart above shows Viking Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Viking Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Viking Therapeutics' option, there is no secondary market available for investors to trade.
Viking Therapeutics Maximum Pain Price across 2024-05-31 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Viking Therapeutics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Viking Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Viking Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Viking stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Viking Therapeutics' stock price goes up or down, the stock options follow.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viking Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Please note that buying 'in-the-money' options on Viking Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Viking Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Viking Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Viking Stock moves the wrong way.
At this time, Viking Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 763.1 M in 2024, whereas Common Stock Total Equity is likely to drop 582.51 in 2024. Viking Therapeutics In The Money Call Balance
When Viking Therapeutics' strike price is surpassing the current stock price, the option contract against Viking Therapeutics stock is said to be in the money. When it comes to buying Viking Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Viking Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Viking Current Options Market Mood
Viking Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Viking Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Viking Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Viking Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Viking Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Viking contract
Base on the Rule 16, the options market is currently suggesting that Viking Therapeutics will have an average daily up or down price movement of about 6.43% per day over the life of the 2024-05-31 option contract. With Viking Therapeutics trading at USD 62.75, that is roughly USD 4.04. If you think that the market is fully incorporating Viking Therapeutics' daily price movement you should consider buying Viking Therapeutics options at the current volatility level of 102.96%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Viking |
Purchasing Viking Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Viking calls. Remember, the seller must deliver Viking Therapeutics stock to the call owner when a call is exercised.
Viking Therapeutics Option Chain
When Viking Therapeutics' strike price is surpassing the current stock price, the option contract against Viking Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-05-312024-06-072024-06-142024-06-212024-06-282024-07-052024-07-192024-08-162024-09-202024-11-152025-01-172026-01-16
Viking Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Viking. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Viking. It also shows strike prices and maturity days for a Viking Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-31 CALL at $40.0 | 0.8831 | 0.0066 | 0 | 2024-05-31 | 20.5 - 24.9 | 0.0 | In |
Call | 2024-05-31 CALL at $44.5 | 0.8568 | 0.0091 | 0 | 2024-05-31 | 16.0 - 20.5 | 0.0 | In |
Call | 2024-05-31 CALL at $45.0 | 0.8537 | 0.0094 | 0 | 2024-05-31 | 15.5 - 20.0 | 0.0 | In |
Call | 2024-05-31 CALL at $45.5 | 0.996 | 0.0015 | 0 | 2024-05-31 | 15.0 - 19.6 | 0.0 | In |
Call | 2024-05-31 CALL at $46.0 | 0.8532 | 0.0103 | 0 | 2024-05-31 | 14.5 - 18.8 | 0.0 | In |
Call | 2024-05-31 CALL at $46.5 | 0.983 | 0.0046 | 0 | 2024-05-31 | 14.1 - 18.6 | 0.0 | In |
Call | 2024-05-31 CALL at $47.0 | 0.8499 | 0.0111 | 0 | 2024-05-31 | 13.5 - 17.7 | 0.0 | In |
Call | 2024-05-31 CALL at $47.5 | 0.8431 | 0.0115 | 0 | 2024-05-31 | 13.0 - 17.3 | 0.0 | In |
Call | 2024-05-31 CALL at $48.0 | 0.9548 | 0.0091 | 0 | 2024-05-31 | 13.0 - 17.0 | 0.0 | In |
Call | 2024-05-31 CALL at $48.5 | 0.9399 | 0.0108 | 0 | 2024-05-31 | 12.8 - 16.4 | 0.0 | In |
Call | 2024-05-31 CALL at $49.0 | 0.8253 | 0.0128 | 0 | 2024-05-31 | 11.5 - 16.0 | 0.0 | In |
Call | 2024-05-31 CALL at $49.5 | 0.8389 | 0.0139 | 0 | 2024-05-31 | 11.1 - 15.0 | 0.0 | In |
Call | 2024-05-31 CALL at $50.0 | 0.9964 | 0.002 | 5 | 2024-05-31 | 10.6 - 15.0 | 27.0 | In |
Call | 2024-05-31 CALL at $51.0 | 0.9376 | 0.0138 | 0 | 2024-05-31 | 10.1 - 14.0 | 0.0 | In |
Call | 2024-05-31 CALL at $52.0 | 0.8166 | 0.0175 | 0 | 2024-05-31 | 8.7 - 12.5 | 0.0 | In |
Call | 2024-05-31 CALL at $53.0 | 0.997 | 0.0023 | 0 | 2024-05-31 | 7.6 - 12.0 | 0.0 | In |
Call | 2024-05-31 CALL at $54.0 | 0.8153 | 0.0226 | 0 | 2024-05-31 | 6.7 - 10.9 | 10.1 | In |
Call | 2024-05-31 CALL at $55.0 | 0.8974 | 0.026 | 1 | 2024-05-31 | 6.6 - 9.7 | 8.15 | In |
Call | 2024-05-31 CALL at $56.0 | 0.7659 | 0.0271 | 0 | 2024-05-31 | 4.7 - 8.5 | 0.0 | In |
Call | 2024-05-31 CALL at $57.0 | 0.8975 | 0.036 | 0 | 2024-05-31 | 4.2 - 7.9 | 0.0 | In |
Call | 2024-05-31 CALL at $58.0 | 0.7829 | 0.0428 | 0 | 2024-05-31 | 4.1 - 7.3 | 0.0 | In |
Call | 2024-05-31 CALL at $59.0 | 0.8472 | 0.0598 | 0 | 2024-05-31 | 2.45 - 5.8 | 0.0 | In |
Call | 2024-05-31 CALL at $60.0 | 0.6606 | 0.0445 | 67 | 2024-05-31 | 3.4 - 6.2 | 5.0 | In |
Call | 2024-05-31 CALL at $61.0 | 0.6326 | 0.0593 | 1 | 2024-05-31 | 2.55 - 5.5 | 3.5 | In |
Call | 2024-05-31 CALL at $62.0 | 0.576 | 0.0717 | 28 | 2024-05-31 | 2.55 - 3.2 | 2.59 | In |
Call | 2024-05-31 CALL at $63.0 | 0.5071 | 0.0646 | 87 | 2024-05-31 | 2.15 - 4.2 | 2.37 | Out |
Call | 2024-05-31 CALL at $64.0 | 0.4513 | 0.0589 | 18 | 2024-05-31 | 1.9 - 2.2 | 2.15 | Out |
Call | 2024-05-31 CALL at $65.0 | 0.3963 | 0.0567 | 282 | 2024-05-31 | 1.55 - 2.05 | 2.2 | Out |
Call | 2024-05-31 CALL at $66.0 | 0.3393 | 0.055 | 49 | 2024-05-31 | 0.4 - 1.7 | 1.42 | Out |
Call | 2024-05-31 CALL at $67.0 | 0.3002 | 0.0497 | 141 | 2024-05-31 | 0.6 - 1.4 | 1.26 | Out |
Call | 2024-05-31 CALL at $68.0 | 0.2714 | 0.0444 | 420 | 2024-05-31 | 0.95 - 1.35 | 1.17 | Out |
Call | 2024-05-31 CALL at $69.0 | 0.2134 | 0.0419 | 44 | 2024-05-31 | 0.55 - 2.55 | 0.8 | Out |
Call | 2024-05-31 CALL at $70.0 | 0.2102 | 0.0368 | 384 | 2024-05-31 | 0.8 - 0.95 | 0.88 | Out |
Call | 2024-05-31 CALL at $71.0 | 0.1844 | 0.0333 | 121 | 2024-05-31 | 0.0 - 0.9 | 0.76 | Out |
Call | 2024-05-31 CALL at $72.0 | 0.1538 | 0.03 | 47 | 2024-05-31 | 0.5 - 0.75 | 0.6 | Out |
Call | 2024-05-31 CALL at $73.0 | 0.1598 | 0.0274 | 66 | 2024-05-31 | 0.55 - 0.8 | 0.7 | Out |
Call | 2024-05-31 CALL at $74.0 | 0.1373 | 0.0248 | 21 | 2024-05-31 | 0.0 - 0.8 | 0.58 | Out |
Call | 2024-05-31 CALL at $75.0 | 0.1276 | 0.0227 | 382 | 2024-05-31 | 0.4 - 0.7 | 0.75 | Out |
Call | 2024-05-31 CALL at $76.0 | 0.1158 | 0.0207 | 130 | 2024-05-31 | 0.45 - 0.55 | 0.5 | Out |
Call | 2024-05-31 CALL at $77.0 | 0.1311 | 0.0201 | 31 | 2024-05-31 | 0.4 - 0.65 | 0.65 | Out |
Call | 2024-05-31 CALL at $78.0 | 0.1009 | 0.0176 | 79 | 2024-05-31 | 0.35 - 0.7 | 0.45 | Out |
Call | 2024-05-31 CALL at $79.0 | 0.1005 | 0.0167 | 157 | 2024-05-31 | 0.35 - 0.6 | 0.47 | Out |
Call | 2024-05-31 CALL at $80.0 | 0.0934 | 0.0155 | 1001 | 2024-05-31 | 0.4 - 0.5 | 0.44 | Out |
Call | 2024-05-31 CALL at $81.0 | 0.0809 | 0.0139 | 261 | 2024-05-31 | 0.3 - 0.45 | 0.37 | Out |
Call | 2024-05-31 CALL at $83.0 | 0.0665 | 0.0117 | 15 | 2024-05-31 | 0.3 - 3.8 | 0.3 | Out |
Call | 2024-05-31 CALL at $84.0 | 0.0788 | 0.0122 | 22 | 2024-05-31 | 0.0 - 4.8 | 0.4 | Out |
Call | 2024-05-31 CALL at $85.0 | 0.098 | 0.0128 | 248 | 2024-05-31 | 0.15 - 1.0 | 0.45 | Out |
Call | 2024-05-31 CALL at $90.0 | 0.0499 | 0.008 | 1492 | 2024-05-31 | 0.25 - 0.3 | 0.25 | Out |
Call | 2024-05-31 CALL at $100.0 | 0.029 | 0.0046 | 1327 | 2024-05-31 | 0.15 - 0.2 | 0.15 | Out |
Call | 2024-05-31 CALL at $105.0 | 0.0337 | 0.0046 | 39 | 2024-05-31 | 0.0 - 0.2 | 0.2 | Out |
Call | 2024-05-31 CALL at $120.0 | 0.0208 | 0.0027 | 12 | 2024-05-31 | 0.0 - 4.8 | 0.13 | Out |
Put | 2024-05-31 PUT at $53.0 | -0.0331 | 0.0124 | 0 | 2024-05-31 | 0.0 - 4.8 | 0.08 | Out |
Put | 2024-05-31 PUT at $55.0 | -0.0838 | 0.0246 | 52 | 2024-05-31 | 0.0 - 0.5 | 0.25 | Out |
Put | 2024-05-31 PUT at $57.0 | -0.142 | 0.0379 | 27 | 2024-05-31 | 0.0 - 1.5 | 0.45 | Out |
Put | 2024-05-31 PUT at $58.0 | -0.1822 | 0.0456 | 28 | 2024-05-31 | 0.0 - 1.0 | 0.6 | Out |
Put | 2024-05-31 PUT at $59.0 | -0.2515 | 0.0505 | 15 | 2024-05-31 | 0.0 - 1.05 | 1.0 | Out |
Put | 2024-05-31 PUT at $60.0 | -0.2923 | 0.0603 | 226 | 2024-05-31 | 0.95 - 1.3 | 1.1 | Out |
Put | 2024-05-31 PUT at $61.0 | -0.366 | 0.0606 | 22 | 2024-05-31 | 0.9 - 2.35 | 1.65 | Out |
Put | 2024-05-31 PUT at $62.0 | -0.4284 | 0.065 | 141 | 2024-05-31 | 1.4 - 3.4 | 2.02 | Out |
Put | 2024-05-31 PUT at $63.0 | -0.499 | 0.0761 | 41 | 2024-05-31 | 1.7 - 2.7 | 2.86 | In |
Put | 2024-05-31 PUT at $64.0 | -0.5568 | 0.0636 | 82 | 2024-05-31 | 2.9 - 3.4 | 3.45 | In |
Put | 2024-05-31 PUT at $65.0 | -0.6163 | 0.0609 | 274 | 2024-05-31 | 3.5 - 3.9 | 3.8 | In |
Put | 2024-05-31 PUT at $66.0 | -0.6323 | 0.0483 | 459 | 2024-05-31 | 4.4 - 5.2 | 5.05 | In |
Put | 2024-05-31 PUT at $67.0 | -0.6627 | 0.0437 | 19 | 2024-05-31 | 3.5 - 6.2 | 5.95 | In |
Put | 2024-05-31 PUT at $68.0 | -0.7088 | 0.0422 | 50 | 2024-05-31 | 5.5 - 7.3 | 6.6 | In |
Put | 2024-05-31 PUT at $69.0 | -0.7314 | 0.0383 | 32 | 2024-05-31 | 6.2 - 9.1 | 7.53 | In |
Put | 2024-05-31 PUT at $70.0 | -0.7688 | 0.0359 | 153 | 2024-05-31 | 6.5 - 9.4 | 8.28 | In |
Put | 2024-05-31 PUT at $71.0 | -0.7696 | 0.0321 | 302 | 2024-05-31 | 8.0 - 10.3 | 9.39 | In |
Put | 2024-05-31 PUT at $72.0 | -0.7697 | 0.0291 | 476 | 2024-05-31 | 8.0 - 10.9 | 10.5 | In |
Put | 2024-05-31 PUT at $73.0 | -0.7875 | 0.0271 | 11 | 2024-05-31 | 9.8 - 11.9 | 11.4 | In |
Put | 2024-05-31 PUT at $74.0 | -0.8325 | 0.0254 | 6 | 2024-05-31 | 11.1 - 12.6 | 12.03 | In |
Put | 2024-05-31 PUT at $75.0 | -0.8605 | 0.0231 | 54 | 2024-05-31 | 12.0 - 13.7 | 11.8 | In |
Put | 2024-05-31 PUT at $76.0 | -0.9409 | 0.016 | 7 | 2024-05-31 | 11.6 - 15.2 | 13.57 | In |
Put | 2024-05-31 PUT at $77.0 | -0.837 | 0.0208 | 5 | 2024-05-31 | 14.0 - 16.3 | 13.65 | In |
Put | 2024-05-31 PUT at $79.0 | -0.9041 | 0.0164 | 0 | 2024-05-31 | 14.5 - 18.8 | 11.13 | In |
Put | 2024-05-31 PUT at $80.0 | -0.8734 | 0.017 | 39 | 2024-05-31 | 15.5 - 19.9 | 17.92 | In |
Put | 2024-05-31 PUT at $81.0 | -0.8788 | 0.016 | 2 | 2024-05-31 | 16.8 - 21.0 | 10.0 | In |
Put | 2024-05-31 PUT at $82.0 | -0.8872 | 0.0151 | 7 | 2024-05-31 | 17.8 - 21.9 | 11.14 | In |
Put | 2024-05-31 PUT at $83.0 | -0.9013 | 0.0138 | 10 | 2024-05-31 | 18.7 - 22.8 | 11.1 | In |
Put | 2024-05-31 PUT at $84.0 | -0.9161 | 0.0125 | 3 | 2024-05-31 | 19.3 - 24.0 | 11.7 | In |
Put | 2024-05-31 PUT at $85.0 | -0.9385 | 0.0105 | 1 | 2024-05-31 | 20.2 - 24.8 | 12.7 | In |
Put | 2024-05-31 PUT at $86.0 | -0.8866 | 0.013 | 0 | 2024-05-31 | 21.9 - 26.0 | 0.0 | In |
Put | 2024-05-31 PUT at $87.0 | -0.9214 | 0.0109 | 0 | 2024-05-31 | 22.3 - 27.0 | 0.0 | In |
Put | 2024-05-31 PUT at $88.0 | -0.8644 | 0.0127 | 0 | 2024-05-31 | 24.5 - 28.0 | 0.0 | In |
Put | 2024-05-31 PUT at $89.0 | -0.8926 | 0.0116 | 0 | 2024-05-31 | 24.9 - 29.0 | 0.0 | In |
Put | 2024-05-31 PUT at $90.0 | -0.9379 | 0.009 | 2 | 2024-05-31 | 25.4 - 29.7 | 26.0 | In |
Put | 2024-05-31 PUT at $91.0 | -0.939 | 0.0086 | 0 | 2024-05-31 | 26.1 - 31.0 | 0.0 | In |
Put | 2024-05-31 PUT at $95.0 | -0.9313 | 0.0083 | 0 | 2024-05-31 | 30.3 - 35.0 | 0.0 | In |
Put | 2024-05-31 PUT at $100.0 | -0.9465 | 0.0065 | 0 | 2024-05-31 | 35.1 - 40.0 | 0.0 | In |
Put | 2024-05-31 PUT at $105.0 | -0.9615 | 0.005 | 2 | 2024-05-31 | 40.0 - 44.9 | 39.06 | In |
Put | 2024-05-31 PUT at $110.0 | -0.9634 | 0.0044 | 0 | 2024-05-31 | 45.0 - 49.9 | 0.0 | In |
Put | 2024-05-31 PUT at $115.0 | -0.9541 | 0.0047 | 0 | 2024-05-31 | 50.1 - 55.0 | 0.0 | In |
Viking Therapeutics Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Viking Therapeutics Common Stock Total Equity Over Time
The total value of common stock equity held by shareholders, representing their ownership interest in the company. Common Stock Total Equity |
| Timeline |
Viking Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Viking Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Already Invested in Viking Therapeutics?
The danger of trading Viking Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Viking Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Viking Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Viking Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Viking Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Viking Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Viking Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Viking Therapeutics Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viking Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Viking Stock analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Viking Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viking Therapeutics. If investors know Viking will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viking Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Return On Assets (0.13) | Return On Equity (0.18) |
The market value of Viking Therapeutics is measured differently than its book value, which is the value of Viking that is recorded on the company's balance sheet. Investors also form their own opinion of Viking Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viking Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viking Therapeutics' market value can be influenced by many factors that don't directly affect Viking Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viking Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viking Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viking Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.